Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Karen E. Hansen"'
Autor:
Karen E. Hansen, Mahta Mortezavi, Edward Nagy, Cunshan Wang, Carol A. Connell, Zaher Radi, Heather J. Litman, Giovanni Adami, Maurizio Rossini
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Background: Preclinical data suggest that tofacitinib would protect bone health in patients with rheumatoid arthritis (RA). Objective: To assess fracture risk in tofacitinib RA clinical trials. Design: Post hoc analysis. Methods: We analyzed pooled d
Externí odkaz:
https://doaj.org/article/1d9b75146dd846feab811b470e6f4c89
Autor:
Haukur T. Gudmundsson, Karen E. Hansen, Bjarni V. Halldorsson, Bjorn R. Ludviksson, Bjorn Gudbjornsson
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Although osteoporosis is an easily diagnosed and treatable condition, many individuals remain untreated. Clinical decision support systems might increase appropriate treatment of osteoporosis. We designed the Osteoporosis Advisor
Externí odkaz:
https://doaj.org/article/a86d479b04b94aa18489a55d900c2b80
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 15, Iss , Pp 30-35 (2018)
Background: Low bone mineral density (BMD) and subsequent skeletal fragility have emerged as a long-term complication of phenylketonuria (PKU). Objective: To determine if there are differences in BMD and body composition between male and female parti
Externí odkaz:
https://doaj.org/article/aba741ad207e40f2a24c1c1c339808d8
Autor:
Bridget M. Stroup, Emily A. Sawin, Sangita G. Murali, Neil Binkley, Karen E. Hansen, Denise M. Ney
Publikováno v:
Journal of Nutrition and Metabolism, Vol 2017 (2017)
Background. Skeletal fragility is a complication of phenylketonuria (PKU). A diet containing amino acids compared with glycomacropeptide reduces bone size and strength in mice. Objective. We tested the hypothesis that amino acid medical foods (AA-MF)
Externí odkaz:
https://doaj.org/article/5bb5275fdfc048329cbb4911901c30e5
Publikováno v:
The Journal of Nutrition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37469b965ac313b6d73111c4ecceab99
https://doi.org/10.1016/j.tjnut.2023.03.014
https://doi.org/10.1016/j.tjnut.2023.03.014
Autor:
Julia Amariti, Brandon D. McGuire, Anna R. Ogilvie, Kristen M. Beavers, Karen E. Hansen, Yvette Schlussel, Michael P. Walkup, Sue A. Shapses
Publikováno v:
Calcified Tissue International. 111:137-144
Obesity is a risk factor for chronic diseases and moderate weight loss is generally recommended. Energy restriction results in the loss of hip bone mineral density (BMD) in older adults, but there is no consistent decline at the lumbar spine (LS), po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9aff3870f839b2959430a71bc76b57
https://doi.org/10.1007/s00223-022-00973-1
https://doi.org/10.1007/s00223-022-00973-1
Autor:
Zeina A Yanbeiy, Karen E. Hansen
Publikováno v:
Drug Design, Development and Therapy. 13:2843-2852
Objective Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. In May 2018, denosumab was approved for the treatment of GIOP in men and women at high risk of fracture. We undertook a systematic review and meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d1dccde6e9f13ceb67492a291dfe291
https://doi.org/10.2147/dddt.s148654
https://doi.org/10.2147/dddt.s148654
The −839(A/C) Polymorphism in the ECE1 Isoform b Promoter Associates With Osteoporosis and Fractures
Autor:
Tonia C. Carter, Michael G. Johnson, Robert D. Blank, Karen E. Hansen, Nicholas S. Keuler, John E. Mayer
Publikováno v:
Journal of the Endocrine Society. 3:2041-2050
Context We previously found that variation in a quantitative trait locus, including the gene-encoding endothelin-converting enzyme 1 (Ece1), accounted for 40% of the variance in bone biomechanics and bone mineral density (BMD) in an intercross of rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76a123b279d5da1e6835d77b402a3b7b
https://doi.org/10.1210/js.2019-00057
https://doi.org/10.1210/js.2019-00057
Publikováno v:
Osteoporosis International. 30:2019-2025
Doctors do not know whether treatment of high parathyroid hormone levels is linked to better outcomes in their patients with kidney disease. In this study, lower parathyroid hormone levels at baseline were linked to lower risk of fracture, vascular e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f608be5ca67469de8137fc27213b704
https://doi.org/10.1007/s00198-019-05033-3
https://doi.org/10.1007/s00198-019-05033-3
Autor:
Shivani Garg, Michael G. Semanik, Yabing Huang, Christie M. Bartels, Weixiong Zhong, Sarah E. Panzer, Karen E. Hansen, Maureen A. Smith
Publikováno v:
Arthritis Care Res (Hoboken)
Objective Cardiovascular disease (CVD) is accelerated in patients with systemic lupus erythematosus and lupus nephritis (LN). Despite the literature suggesting that renal arteriosclerosis predicts CVD in other glomerulonephritis diseases, arterioscle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015bab422c462a2d7a4f72d5f9b72f68
https://europepmc.org/articles/PMC8162670/
https://europepmc.org/articles/PMC8162670/
